Start Date
August 15, 2022
Primary Completion Date
May 22, 2025
Study Completion Date
May 22, 2025
cePolytreg
The treatment group will receive cePolyTregs 2 weeks after islet transplantation as immunotherapy to improve islet survival and reduce the need for immunosuppression drugs.
University of Alberta Hospital, Edmonton
Collaborators (1)
Juvenile Diabetes Research Foundation
OTHER
Juvenile Diabetes Research Foundation Canadian Clinical Trial Network
UNKNOWN
University of Alberta
OTHER